Trial Profile
A real world study to evaluate the long term ischemic and bleeding events in patients with post acute myocardial infarction undergone percutaneous coronary intervention treated with Clopidogrel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jun 2017
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 17 Jun 2017 New trial record